Marleen Bérouti

Marleen Bérouti

Auto-generated profile, based on publicly available information

Marleen Bérouti

Ludwig-Maximilians-Universität München 1 Gene Center and Department of Biochemistry Munich

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2024 in Immunity
Verified
Journal Article
Open access
MBMarleen Bérouti
Marleen Bérouti
KLKatja Lammens
Katja Lammens
MHMatthias Heiss
Matthias Heiss
LHLarissa Hansbauer
Larissa Hansbauer
SBStefan Bauernfried
Stefan Bauernfried
VHVeit Hornung
Veit Hornung
Toll-like receptor 7 (TLR7) is essential for recognition of RNA viruses and initiation of antiviral immunity. TLR7 contains two ligand-binding pockets that recognize different RNA degradation products: pocket 1 recognizes guanosine, while pocket 2 coordinates pyrimidine-rich RNA fragments. We found that the endonuclease RNase T2, along with 5' exonucleases PLD3 and PLD4, collaboratively generate the ligands for TLR7. Specifically, RNase T2 generated guanosine 2',3'-cyclic monophosphate-terminated RNA fragments. PLD exonuclease activity further released the terminal 2',3'-cyclic guanosine monophosphate (2',3'-cGMP) to engage pocket 1 and was also needed to generate RNA fragments for pocket 2. Loss-of-function studies in cell lines and primary cells confirmed the critical requirement for PLD activity. Biochemical and structural studies showed that PLD enzymes form homodimers with two ligand-binding sites important for activity. Previously identified disease-associated PLD mutants failed to form stable dimers. Together, our data provide a mechanistic basis for the detection of RNA fragments by TLR7.

1 June 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
NSNiklas Arndt Schmacke
Niklas Arndt Schmacke
SMSophia C. Mädler
Sophia C. Mädler
GWGeorg Wallmann
Georg Wallmann
AMAndreas Metousis
Andreas Metousis
MBMarleen Bérouti
Marleen Bérouti
VHVeit Hornung
Veit Hornung
Forward genetic screening associates phenotypes with genotypes by randomly inducing mutations and then identifying those that result in phenotypic changes of interest. Here we present spa tially r esolved C RISPR s creening (SPARCS), a platform for microscopy-based genetic screening for spatial cellular phenotypes. SPARCS uses automated high-speed laser microdissection to physically isolate phenotypic variants in situ from virtually unlimited library sizes. We demonstrate the potential of SPARCS in a genome-wide CRISPR-KO screen on autophagosome formation in 40 million cells. Coupled to deep learning image analysis, SPARCS recovered almost all known macroautophagy genes in a single experiment and discovered a role for the ER-resident protein EI24 in autophagosome biogenesis. Harnessing the full power of advanced imaging technologies, SPARCS enables genome-wide forward genetic screening for diverse spatial phenotypes in situ .

24 January 2025 in Journal of Experimental Medicine
Verified
Journal Article
Closed access
CGCarlos Gomez-Diaz
Carlos Gomez-Diaz
WGWilhelm Greulich
Wilhelm Greulich
BWBenedikt Wefers
Benedikt Wefers
MWMeiyue Wang
Meiyue Wang
SBSilvia Bolsega
Silvia Bolsega
VHVeit Hornung
Veit Hornung
RNA-sensing TLRs are strategically positioned in the endolysosome to detect incoming nonself RNA. RNase T2 plays a critical role in processing long, structured RNA into short oligoribonucleotides that engage TLR7 or TLR8. In addition to its positive regulatory role, RNase T2 also restricts RNA recognition through unknown mechanisms, as patients deficient in RNase T2 suffer from neuroinflammation. Consistent with this, mice lacking RNase T2 exhibit interferon-dependent neuroinflammation, impaired hematopoiesis, and splenomegaly. However, the mechanism by which RNase T2 deficiency unleashes inflammation in vivo remains unknown. Here, we report that the inflammatory phenotype found in Rnaset2−/− mice is completely reversed in the absence of TLR13, suggesting aberrant accumulation of an RNA ligand for this receptor. Interestingly, this TLR13-driven inflammatory phenotype is also fully present in germ-free mice, suggesting a role for RNase T2 in limiting erroneous TLR13 activation by an as yet unidentified endogenous ligand. These results establish TLR13 as a potential self-sensor that is kept in check by RNase T2.